By Brandon Moseley
Alabama Political Reporter
Wednesday, August 20, U.S. Senator Jeff Session was in Fayette County touring the Showa Best Glove factory in the city of Fayette.
Showa manufactures the modern equivalent of the old “rubber glove” the synthetic glove that has become an essential protection for workers and customers alike in medicine as well as in fields such as: first responders, agricultural processors, food processing, chemical manufacturers, fishermen, and a host of other commercial and industrial occupations. Showa faces enormous challenges on the world market from foreign competition and from an increasingly stringent federal regulatory environment.
Senator Sessions told the Alabama Political Reporter, “The world is very competitive. So if government regulation or governmental policy puts a company at a disadvantage, the company might lose out to a manufacturer in Canada, Mexico, China or some other place. So I like to hear what people are saying. We’ve had concerns about things like excessive environmental regulations and the government demanding things that cannot economically be accomplished. These types of regulations are unwise because it just makes companies more fragile, and money is basically getting wasted on regulations that don’t produce a benefit. Some regulations do produce a benefit, but some don’t.”
According to the 2014/2015 West Alabama Mining and Manufacturing Directory, Showa Best Glove Manufacturing is the top manufacturing employer in Fayette County. Bill Trank is the plant manager. Trank led Sessions on a tour of the plant which employs over 300 and runs 24 hours a day seven days a week.
Trank said that the plant daily turns over 6000 gallons of nitrile into 1.2 to 1.3 million gloves per day. Trank said that the gloves are purchased by: EMTs, laboratories, food processors, tattoo parlors, dentists, healthcare providers, and sanitation and maintenance workers and for industrial use. Trank said that they would like to sell more gloves to hospitals, but currently most hospitals order their supplies through a handful of hospital supply companies and those suppliers often prefer to purchase the cheapest gloves, not the best gloves.
Sen. Sessions said that it is important that we make things in this country and said that we have got to get this economy growing faster to improve the job situation.
One of the managers told Sessions that his job was to keep up with all of the regulations that the federal government placed on the plant. Sessions said, “Your job is secure.”
Trank said that the plant began in the 1960s. Gillette had a factory across the street in Fayette that assembled surgical kits for doctors and hospitals. Gillette was encountering problems getting a consistent supply of rubber gloves for their kit so they built their own rubber glove factory there at 931 2nd Avenue SE in Fayette.
The original plant made 80,000 rubber gloves a day. Eventually people developed a sensitivity to the rubber gloves. The synthetic glove was invented. The synthetic latex glove replaced the old natural rubber gloves over time. Showa has since invented a non-latex synthetic glove when people developed a sensitivity to latex.
Eventually Gillette went out of the surgical kit business and the glove factory was sold to an investor in Boston. Showa Best Gloves is run today as a closely held company with its headquarters in Menlo, Georgia. The plant was enlarged in the 1980s and 1990s to its present size and capacity.
Showa Best Glove is the inventor of the world’s first disposable nitrile glove, N-DEX®. Best Glove has now patented the world’s first biodegradable disposable nitrile glove, GreeN-DEX™. The Showa Best Glove’s Research & Development team has developed a process to manufacture a disposable glove that is biodegradable in biologically active landfills and anaerobic digesters while still retaining all the performance of its classic N-DEX® gloves.
Trank said that the company is in talks with Wal-Mart about carrying its gloves there for direct sales to the general public.
According to the company website, Showa Best Gloves manufactures more than 1800 individual glove choices in a variety of styles for use primarily in the construction, industrial, automotive, healthcare, retail and commercial fishing industries. Showa is recognized internationally for innovative technology and superior quality, the company manages the entire production process, from research and development to manufacturing to product management.
Showa manufactures a diverse line of gloves that include: ATLAS®, the world’s most popular brand of flat-dipped, latex-palm-coated gloves; N-DEX®, the industry’s first non-latex, non-vinyl disposable glove; the new AEGIS KVS4™, which combines a level 4 cut-resistant liner with a durable, sponge nitrile patented Zorb-IT® palm coating that blends KEVLAR®, stainless steel and polyester to provide comfortable cut-resistance; the new AEGIS HP54 ™ glove combines High Performance Polyethylene (HPPE), nylon, and Lycra with an oil resistant ZorbIT® palm coating to offer the wearer ANSI Level 4 cut protection with max-comfort; and the S-TEX line providing extra cut protection, featuring a patented Hagane Coil™ fiber technology, a trusted Kevlar® shell, and/or enhanced High-Vis colors – depending on the style selected.
Showa is an active member in the: Industrial Glove Association (IGA); Safety Equipment Distributors Association; International Hand Protection Association; American Industrial Hygiene Association; American Society for Testing and Materials; European Standardization Committee (CEN); National Fire Protection Association and the Industrial Safety Equipment Association.
Senator Jeff Sessions has served the people of Alabama for 18 years in the United States Senate and is seeking a fourth term.
USDA is seeking rural energy grant applications
The deadlines to apply for grants is Feb. 1, 2021, and March 31, 2021. Applications for loan guarantees are accepted year-round.
United States Department of Agriculture Deputy Under Secretary for Rural Development Bette Brand on Wednesday invited applications for loan guarantees and grants for renewable energy systems, and to make energy efficiency improvements, conduct energy audits and provide development assistance.
The funding is being provided through the USDA’s Rural Energy for America Program, which was created under the 2008 Farm Bill and reauthorized under the 2018 Farm Bill. This notice seeks applications for Fiscal Year 2021 funding.
The deadlines to apply for grants is Feb. 1, 2021, and March 31, 2021. Applications for loan guarantees are accepted year-round.
REAP helps agricultural producers and rural small businesses reduce energy costs and consumption by purchasing and installing renewable energy systems and making energy efficiency improvements in their operations.
Eligible systems may derive energy from wind, solar, hydroelectric, ocean, hydrogen, geothermal or renewable biomass (including anaerobic digesters).
USDA encourages applications that will support recommendations made in the Report to the President of the United States from the Task Force on Agriculture and Rural Prosperity to help improve life in rural America.
Applicants are encouraged to consider projects that provide measurable results in helping rural communities build robust and sustainable economies through strategic investments.
Key strategies include achieving e-Connectivity for rural America, developing the rural economy, harnessing technological innovation, supporting a rural workforce and improving quality of life. For additional information, see the notice in the Federal Register.
Trump says that coronavirus vaccine deliveries will begin within two weeks
Trump said that front-line workers, medical personnel and senior citizens would be the vaccine’s first recipients.
President Donald Trump said Thursday that coronavirus vaccine deliveries will begin as early as next week.
“The whole world is suffering, and we are rounding the curve,” Trump said. “And the vaccines are being delivered next week or the week after.”
Trump made the announcement during a special Thanksgiving holiday message to U.S. troops overseas via teleconference. Trump said that front-line workers, medical personnel and senior citizens would be the vaccine’s first recipients. He also argued that his election opponent, President-elect Joe Biden, should not be given credit for the vaccines, which were developed during the Trump administration.
Trump referred to the vaccines, which were developed and tested in less than ten months as a “medical miracle.”
Regulators at the FDA will review Pfizer’s request for an emergency use authorization for its vaccine developed with BioNTech during a meeting on Dec. 10. The director of the FDA’s Center for Biologics Evaluation and Research says a decision is expected within weeks, possibly days after that key meeting.
The latest trial data for Pfizer and BioNTech’s vaccine showed that it was 90 percent effective.
The CDC plans to vote next week on where the distribution of approved vaccines will begin and who will be allowed to get the first vaccines when they become available.
Dr. Celene Gounder, a member of Biden’s COVID Advisory Board, warned against rushing a vaccine to market.
“The single biggest risk of rushing an approval would be Americans’ distrust the vaccine,” Grounder said. “It’s essential people feel confident this is a safe and effective vaccine.”
Moderna said that its vaccine is 94.5 percent effective in preventing COVID-19.
AstraZeneca says its preliminary results showed its vaccine ranged from 62 percent to 90 percent effective depending on the dosage amount given to participants. AstraZeneca is having to launch a second round of global trials to clear up the discrepancies.
Many Americans appear to have ignored CDC warnings to scale back Thanksgiving holiday plans. More than six million Americans flew over the holiday week, raising fears by public health officials that the surge in coronavirus cases we are experiencing now will be followed by a bigger surge in the next three weeks.
As of press time, there have been 62 million diagnosed cases of coronavirus cases in the world, including nearly 13.5 million in the United States, but many cases are mild and go undiagnosed.
A CDC researcher estimates that the real number of infections in the U.S. has topped 53 million since February. More than 1.4 million people have died around the world since the virus first appeared in China late last year. The death toll includes 271,029 Americans and 3,572 Alabamians.
The Iron Bowl is today
Alabama will have to play without head football coach Nick Saban who has tested positive for the coronavirus.
The Auburn University college football team will play the University of Alabama at Bryant-Denny Stadium in Tuscaloosa on Saturday with the game kicking off at 2:30 p.m. Attendance is strictly limited because of COVID-19 restrictions. The game will be televised on CBS stations.
Alabama will have to play without head football coach Nick Saban who has tested positive for the coronavirus and is experiencing mild symptoms. Offensive coordinator Steve Sarkisian will coach the Crimson Tide in Saban’s absence. He has a 46-35 record as a head coach at USC and Washington.
Auburn will be coached by Gus Malzahn, who has a 67-33 record as a head coach. He is the fifth winningest coach in Auburn history, trailing only Shug Jordan, Mike Donahue, Pat Dye and now-Senator-elect Tommy Tuberville.
Alabama has a 7-0 record and is currently the No. 1 team in the country in the college football rankings. Auburn is 5-2 but with a win could still win the SEC West with wins in its remaining two games, and if Alabama were to lose another game down the stretch. Alabama is just one game ahead of Texas A&M for first place in the SEC West, but the Tide has the tiebreaker by virtue of having defeated the Aggies in head-to-head competition.
In addition to team honors, there is a lot riding for individual players in today’s game. Alabama redshirt junior quarterback Mac Jones has thrown for 2,426 yards and 18 touchdowns in Alabama’s first seven games. Jones’s strong performance has made him a Heisman contender and has earned him consideration as a possible first-round or high second-round draft pick by the NFL if he were to leave Alabama early.
Auburn quarterback Bo Nix has thrown for 1,627 yards and ten touchdowns over seven games.
Alabama and Auburn played their first football game against each other in Lakeview Park in Birmingham on Feb. 22, 1893. The game is called the Iron Bowl because historically the game was played on a neutral site: Birmingham’s historic Legion Field. Birmingham at the time was best known for the iron that was mined there and then made into steel and other metal products.
The game is now played as a home and home series, but the Iron Bowl name has stuck with the rivalry.
Alabama leads the series with 46 wins to Auburn’s 37. There has been one tie. Auburn defeated Alabama 48 to 45 in last year’s high scoring contest.
Vaccines should protect against mutated strains of coronavirus
Public health experts say it will be some time before vaccines are available to the wider public.
Multiple vaccines for COVID-19 are in clinical trials, and one has already applied for emergency use authorization, but how good will those vaccines be against a mutating coronavirus? A UAB doctor says they’ll do just fine.
Dr. Rachael Lee, UAB’s hospital epidemiologist, told reporters earlier this week that there have been small genetic mutations in COVID-19. What researchers are seeing in the virus here is slightly different than what’s seen in the virus in China, she said.
“But luckily the way that these vaccines have been created, specifically the mRNA vaccines, is an area that is the same for all of these viruses,” Lee said, referring to the new type of vaccine known as mRNA, which uses genetic material, rather than a weakened or inactive germ, to trigger an immune response.
The U.S. Food And Drug Administration is to review the drug company Pfizer’s vaccine on Dec. 10. Pfizer’s vaccine is an mRNA vaccine, as is a vaccine produced by the drug maker Moderna, which is expected to also soon apply for emergency use approval.
“I think that is incredibly good news, that even though we may see some slight mutations, we should have a vaccine that should cover all of those different mutations,” Lee said.
Researchers at the University of North Carolina at Chapel Hill and the University of Wisconsin-Madison found in a recent study, published in the journal Science, that COVID-19 has mutated in ways that make it spread much more easily, but the mutation may also make it more susceptible to vaccines.
In a separate study, researchers with the Commonwealth Scientific and Industrial Research Organisation found that while most vaccines were modeled after an earlier strain of COVID-19, they found no evidence that the vaccines wouldn’t provide the same immunity response for the new, more dominant strain.
“This brings the world one step closer to a safe and effective vaccine to protect people and save lives,” said CSIRO chief executive Dr. Larry Marshall, according to Science Daily.
While it may not be long before vaccines begin to be shipped to states, public health experts warn it will be some time before vaccines are available to the wider public. Scarce supplies at first will be allocated for those at greatest risk, including health care workers who are regularly exposed to coronavirus patients, and the elderly and ill.
Alabama State Health Officer Dr. Scott Harris, speaking to APR last week, urged the public to continue wearing masks and practicing social distancing for many more months, as the department works to make the vaccines more widely available.
“Just because the first shots are rolling out doesn’t mean it’s time to stop doing everything we’ve been trying to get people to do for months. It’s not going to be widely available for a little while,” Harris said.